About
CDMO providing manufacturing Cell & gene therapy services and testing services from process development to commercial
Areas of Focus
Categories
Contract ManufacturingContract ManufacturingContract Manufacturing
Clinical Trials (2)
View allTotal Trials
2
As Lead Sponsor
0
As Collaborator
2
Total Enrollment
30
By Phase
PHASE1/PHASE2: 1PHASE2: 1
By Status
ACTIVE_NOT_RECRUITING: 2
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Today
Hover over trial bars to see details
Recent Trials
NCT03441958Collaborator
ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma
PHASE1/PHASE2Active, not recruiting
20 participants
Started: Mar 7, 2018 · Completed: Oct 17, 2025
NCT03413800Collaborator
Len/Dex/DLI in Relapsed Multiple Myeloma After Allogeneic Stem Cell Transplant
PHASE2Active, not recruiting
10 participants
Started: Feb 12, 2018 · Completed: Jan 1, 2026
Locations (1)
Headquarters
Montréal, QC, Canada
Map
Loading map...